Login

Research: It's All About Patients - Dr. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Research: It's All About Patients

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Michael Meding Highlights Mchan Mining's High-Value Copper Assets and Strategic Investments
00:10:00
Transforming Lands, Building Futures: A Conversation on Agricultural Development | Alejandro Elsztain, CEO, CRESUD S.A.C.I.F. y A.
00:00:00
Dr. Stephen Mcleod, CEO of the American Academy of Ophthalmology
00:10:00
advice for open source founders|Astasia Myers, Founding Partner,Quiet Capital
00:00:00
Per Andersson, Chief Executive Officer at Xspray Pharma
00:10:00
Midas Gold Highlights Idaho Gold Project at One-to-One Mining Investment Conference
00:10:00
BoxGroup is an early-stage investment fund|Adam Rothenburg,Partner,BoxGroup
00:10:00
Angshu Mallick Reviews Adani Wilmar's IPO Journey and Market Potential | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
Heavy Minerals PLC: Advancing Gold and Copper Projects in Ethiopia and Saudi Arabia
00:00:00
NetScientific PLC present at the Proactive One2One Investor Forum - January 26th 2023 - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:10:00
Latest Queensway Project Update: VP Melissa Render Shares Key News | Melissa Render, V.P. of Exploration of New Found Gold Corp.
00:10:00
Believes that creating something of true significance starts with seeing things others do not|Pete Flint,General Partner,NFX

© 2026 Nehu